An interventional study of Text Message Instructions/Motivation in Colorectal Cancer, sponsored by NYU Langone Health. Completed at 1 site in United States. Open to participants aged 45 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-20.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Screening
Colorectal cancer is a common but preventable condition, and increasing colorectal cancer screening is one of the most impactful public health contributions in the field of gastroenterology. Text messaging is a simple, cheap, and rapid method to reach patients that may improve adherence to colonoscopy appointments as well as simplify the process of bowel preparation. The purpose of the study is to evaluate the feasibility of a pilot bidirectional text messaging intervention on attendance for screening/surveillance colonoscopy and bowel preparation quality at an urban VA hospital. The goal is to improve adherence to colonoscopy among patients who are due for a repeat colonoscopy.
5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,458 are open to participants now.
This study's enrollment of 50 is below the median of 77 across 4,122 interventional studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.
Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants in the experimental arm will receive a series of instructional and motivational text messages, which will be sent starting 7-14 days before and until the day of the colonoscopy procedure.
Behavioral: Text Message Instructions/Motivation
Participants will not receive text messages.
For instructional messages, earlier messages will remind patients of the colonoscopy appointment and later messages will help patients complete the bowel preparation process in real-time. Motivational messages will be sent along with instructional messages.
National Annie Colonoscopy Survey Score
7-item assessment of participant satisfaction with the "Annie" text intervention. Items are rated on a 5-point scale from 1 (strongly disagree) to 5 (strongly agree). The total score is the sum of responses and ranges from 7 to 35; higher scores indicate greater satisfaction with the intervention.
Time frame: Day 21 (Up to 7 Days Post-Procedure)
Percentage of Participants Who Attend Scheduled Colonoscopy Appointment
Assessed via patient's electronic health record.
Time frame: Up to Day 14
Percentage of Participants Who Had Adequate Bowel Preparation at Colonoscopy Appointment
Assessed via patient's electronic health record.
Time frame: Up to Day 14
| Milestone | Text Message Intervention | No Intervention |
|---|---|---|
| Started | 25 | 25 |
| Completed | 25 | 25 |
| Not completed | 0 | 0 |
7-item assessment of participant satisfaction with the "Annie" text intervention. Items are rated on a 5-point scale from 1 (strongly disagree) to 5 (strongly agree). The total score is the sum of responses and ranges from 7 to 35; higher scores indicate greater satisfaction with the intervention.
| Score on a scale | Text Message Intervention | No Intervention |
|---|---|---|
| National Annie Colonoscopy Survey Score | 29.56 ± 4.16 | — |
Assessed via patient's electronic health record.
| Percentage of Participants | Text Message Intervention | No Intervention |
|---|---|---|
| Percentage of Participants Who Attend Scheduled Colonoscopy Appointment | 96 | 92 |
Assessed via patient's electronic health record.
| percentage of participants | Text Message Intervention | No Intervention |
|---|---|---|
| Percentage of Participants Who Had Adequate Bowel Preparation at Colonoscopy Appointment | 79 | 91 |
Collected over 3 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Text Message Intervention | 0/25 (0%) | 0/25 (0%) | 0/25 (0%) |
| No Intervention | 0/25 (0%) | 0/25 (0%) | 0/25 (0%) |
| Age, Continuous(years) | Text Message Intervention | No Intervention | Total |
|---|---|---|---|
| Mean | 65 ± 7.95 | 62.76 ± 6.86 | 63.88 ± 7.43 |
| Sex: Female, Male(Participants) | Text Message Intervention | No Intervention | Total |
|---|---|---|---|
| Female | 2 | 1 | 3 |
| Male | 23 | 24 | 47 |
| Ethnicity (NIH/OMB)(Participants) | Text Message Intervention | No Intervention | Total |
|---|---|---|---|
| Hispanic or Latino | 4 | 7 | 11 |
| Not Hispanic or Latino | 21 | 18 | 39 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Text Message Intervention | No Intervention | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 16 | 12 | 28 |
| White | 5 | 6 | 11 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 4 | 7 | 11 |
| Region of Enrollment(participants) | Text Message Intervention | No Intervention | Total |
|---|---|---|---|
| United States | 25 | 25 | 50 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: peter.liang@nyulangone.org. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.
Supporting information: Study protocol, Sap
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
NYU Langone Health